Login / Signup

Therapeutic Potential of Antibody Targeting Neuronal Pentraxin Receptor in Esophageal Squamous Cell Carcinoma.

Takahiro ShinozukaMitsuro KandaYusuke SatoDai ShimizuShinichi UmedaHideki TakamiNorifumi HattoriMasamichi HayashiChie TanakaYasuhiro Kodera
Published in: Annals of surgical oncology (2024)
NPTXR influences the malignant behavior of ESCC cells. Anti-NPTXR mAb may be a promising therapeutic agent, and its expression in ESCC tissues may serve as a prognostic biomarker.
Keyphrases
  • induced apoptosis
  • poor prognosis
  • cell cycle arrest
  • gene expression
  • binding protein
  • endoplasmic reticulum stress
  • cancer therapy
  • monoclonal antibody
  • drug delivery
  • cell proliferation
  • brain injury